ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

NSABP Accrual To Resume Soon; Group ponders Elections, Move To Fox Chase

May 27, 1994

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

July 10, 1992

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005

Hyperthermia, Radiation Enhancement, New Drugs Offer More Therapy Advances, ASCO Members Hear

April 7, 1978

Oncology Nursing Foundation Offers Research Fellowship, Clinical Scholar Award

September 29, 1995

How NCI Plans To Spend Funds In FY 1980

July 14, 1978